logo
Plus   Neg
Share
Email

DEA Proposes Raising Marijuana Production For Research By 30%

The U.S. Drug Enforcement Administration or DEA has proposed to increase the amount of marijuana that can be produced legally in the U.S. for research by more than 30 percent, while reducing the amount of five opioids manufactured in the country.

The DEA proposes to increase the amount of marijuana that can be produced for research by almost a third over 2019's level, from 2,450 kilograms to 3,200 kilograms. The figure is also almost triple the amount of marijuana produced in 2018.

Over the last two years, the total number of individuals registered by the DEA to conduct research with marijuana, marijuana extracts, derivatives and delta-9-tetrahydrocannabinol or THC increased by more than 40 percent to 542 in January 2019 from 384 in January 2017.

The DEA is a federal law enforcement agency under the U.S. Department of Justice or DoJ. The agency noted that will the proposed increase in marijuana production will meet the need created by the increase in the amount of approved research involving marijuana.

In addition, the DEA proposes to reduce the production of five Schedule II opioid controlled substances that can be manufactured in the U.S. in 2020, compared to 2019.

The DEA proposes to reduce the amount of fentanyl produced in 2020 by 31 percent, hydrocodone by 19 percent, hydromorphone by 25 percent, oxycodone by 9 percent and oxymorphone by 55 percent.

Combined with morphine, the proposed quota would be a 53 percent decrease in the amount of allowable production of these opioids since 2016.

These five opioid substances were subject to special scrutiny following the enactment last year of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, known as the SUPPORT Act.

Public comments will be accepted on the proposed aggregate production quotas or APQs through October 10.

"The aggregate production quota set by DEA each calendar year ensures that patients have the medicines they need while also reducing excess production of controlled prescription drugs that can be diverted and misused," said DEA's Acting Administrator Uttam Dhillon.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Lowe's Companies Inc. (LOW) and Office Depot Inc. (ODP) reported profit for their fourth-quarter, while TJX Companies' (TJX) profit increased 17 percent from the prior year. TJX plans to increase dividend by 13 percent and to buy back up to $2.25 billion of stock. Starbucks is introducing plant-based meat to its menu in Canada in early March. The Seattle-based coffee chain said it will introduce a new Beyond Meat, Cheddar and Egg Sandwich to its Canadian stores on March 3, along with the launch of its new spring menu. The meatless breakfast sandwich will be part of Starbucks Canada's core menu. Auto major Ford Motor Co. issued a safety compliance recall for a total of 217,185 F-150 pickup trucks with LED headlamps in North America, including 50,989 in Canada, to fix issues with the headlamps that could increase risk of a crash. The F-150 has been the top selling U.S. vehicle by any manufacturer for more than 40 years.
Follow RTT
>